TSCAN THERAPEUTICS INC (TCRX) Stock Earnings & Estimates
USA - NASDAQ:TCRX - US89854M1018 - Common Stock
1.78 USD
-0.06 (-3.26%)
1.81 USD
+0.03 (+1.69%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.54M 33.53% | 21.049M 55.46% | 2.816M -86.62% | 10.002M 255.18% | 8.588M -14.14% | 57.755M 572.51% | 54.845M -5.04% | 114.54M 108.84% | 198.69M 73.47% | 396.45M 99.53% | 494.55M 24.74% | |
| EBITDA YoY % growth | -61.5M -35.73% | -88.097M -43.25% | -130.713M -48.37% | -142.107M -8.72% | -163.739M -15.22% | -41.935M 74.39% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -66.64M -37.01% | -93.458M -40.24% | -134.821M -44.26% | -157.739M -17.00% | -169.757M -7.62% | -145.023M 14.57% | -167.687M -15.63% | -126.522M 24.55% | -54.81M 56.68% | 109.78M 300.29% | 168.29M 53.30% | |
| Operating Margin | -492.17% | -444.00% | -4,787.68% | -1,577.07% | -1,976.68% | -251.10% | -305.75% | -110.46% | -27.59% | 27.69% | 34.03% | |
| EPS YoY % growth | -2.75 59.08% | -1.89 31.27% | -1.15 39.15% | -1.16 -0.78% | -1.22 -5.59% | -0.87 28.83% | -1.00 -14.37% | -0.69 31.06% | -0.24 65.35% | 0.62 361.47% | 0.95 52.46% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 -22.22% | -0.29 2.66% | -0.27 -5.14% | -0.30 -5.52% | -0.30 1.97% | -0.29 -0.13% |
| Revenue Q2Q % growth | 2.02M 92.56% | 1.765M 165.41% | 2.339M 7.74% | 1.489M -51.59% | 1.319M -34.70% | 1.319M -25.27% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -40.914M -25.42% | -42.7M -16.31% | -41.616M -14.80% | -42.636M -10.30% | -43.784M -7.01% | -44.549M -4.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.28 | -0.29 | 0.01 | 2.17% |
| Q1 2025 Q2Q % growth | -0.26 18.75% | -0.29 | 0.03 | 10.87% |
| Q4 2024 Q2Q % growth | -0.30 -42.86% | -0.28 | -0.02 | -7.46% |
| Q3 2024 Q2Q % growth | -0.25 -4.17% | -0.29 | 0.04 | 14.81% |
| Q2 2024 Q2Q % growth | -0.28 45.10% | -0.29 | 0.01 | 2.95% |
| Q1 2024 Q2Q % growth | -0.32 65.59% | -0.26 | -0.06 | -22.31% |
| Q4 2023 Q2Q % growth | -0.21 73.08% | -0.30 | 0.09 | 29.01% |
| Q3 2023 Q2Q % growth | -0.24 64.18% | -0.46 | 0.22 | 47.94% |
| Q2 2023 Q2Q % growth | -0.51 19.05% | -0.79 | 0.28 | 35.65% |
| Q1 2023 Q2Q % growth | -0.93 -38.81% | -0.75 | -0.18 | -23.63% |
| Q4 2022 Q2Q % growth | -0.78 -105.26% | -0.72 | -0.06 | -8.85% |
| Q3 2022 Q2Q % growth | -0.67 16.25% | -0.73 | 0.06 | 8.77% |
| Q2 2022 Q2Q % growth | -0.63 91.81% | -0.76 | 0.13 | 17.37% |
| Q1 2022 Q2Q % growth | -0.67 | -0.74 | 0.07 | 9.40% |
| Q4 2021 Q2Q % growth | -0.38 | -0.75 | 0.37 | 49.11% |
| Q3 2021 Q2Q % growth | -0.80 | -0.65 | -0.15 | -22.55% |
| Q2 2021 Q2Q % growth | -7.69 | -2.93 | -4.76 | -162.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 3.076M 473.88% | 1.433M | 1.643M | 114.65% |
| Q1 2025 Q2Q % growth | 2.171M 283.57% | 1.127M | 1.044M | 92.64% |
| Q4 2024 Q2Q % growth | 665K -90.78% | 1.377M | -712K | -51.71% |
| Q3 2024 Q2Q % growth | 1.049M -73.01% | 1.082M | -33K | -3.05% |
| Q2 2024 Q2Q % growth | 536K -82.97% | 2.467M | -1.931M | -78.27% |
| Q1 2024 Q2Q % growth | 566K -91.68% | 4.055M | -3.489M | -86.04% |
| Q4 2023 Q2Q % growth | 7.211M 132.61% | 3.407M | 3.804M | 111.65% |
| Q3 2023 Q2Q % growth | 3.887M 15.68% | 4.17M | -283K | -6.79% |
| Q2 2023 Q2Q % growth | 3.148M -22.46% | 4.111M | -963K | -23.42% |
| Q1 2023 Q2Q % growth | 6.803M 125.26% | 4.49M | 2.313M | 51.51% |
| Q4 2022 Q2Q % growth | 3.1M 8.77% | 3.9M | -800K | -20.51% |
| Q3 2022 Q2Q % growth | 3.36M 39.42% | 3.772M | -412K | -10.92% |
| Q2 2022 Q2Q % growth | 4.06M 42.46% | 3.063M | 997K | 32.55% |
| Q1 2022 Q2Q % growth | 3.02M 48.77% | 2.618M | 402K | 15.36% |
| Q4 2021 Q2Q % growth | 2.85M 256.25% | 3.289M | -439K | -13.35% |
| Q3 2021 Q2Q % growth | 2.41M 731.03% | 2.478M | -68K | -2.74% |
| Q2 2021 Q2Q % growth | 2.85M | 1.088M | 1.762M | 161.95% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.04% | 0% | -1.41% |
| Revenue | 0% | 31.6% | 0% | 41.11% |